Seeing Is Believing
Healthcare - Sector
with an average price target of $3.67. This is a potential upside of $3.67 (0%) from yesterday's end of day stock price of $0.
Meridian Bioscience's activity chart (see below) currently has 38 price targets and 25 ratings on display.
Analysts average stock forecasts to be materialized ratio is 81.67% with an average time for these price targets to be met of 311.25 days.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 08-Jul-2022. First documented stock forecast 04-May-2015.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 08-Jul-2022
$34
$0.03 (0.09%)
$30
3 years 6 months 12 days ago
(08-Jul-2022)
6/9 (66.67%)
$1 (3.03%)
337
Buy
Since 11-Aug-2020
$34
$0.03 (0.09%)
$34
4 years 10 months 28 days ago
(23-Feb-2021)
3/5 (60%)
$12.77 (60.15%)
96
Sell
Since 01-May-2019
$11
6 years 8 months 19 days ago
(01-May-2019)
4/4 (100%)
$-2.29 (-17.23%)
545
Sell
Since 25-Jan-2017
$15
$-18.97 (-55.84%)
$15
6 years 8 months 19 days ago
(01-May-2019)
3/3 (100%)
$3.19 (27.01%)
267
What is VIVO (Meridian Bioscience) average time for price targets to be met?
Which analyst has the current highest performing score on VIVO (Meridian Bioscience) with a proven track record?
Which analyst has the current lower performing score on VIVO (Meridian Bioscience) with a proven track record?
Which analyst has the most public recommendations on VIVO (Meridian Bioscience)?
Which analyst is the currently most bullish on VIVO (Meridian Bioscience)?
Which analyst is the currently most reserved on VIVO (Meridian Bioscience)?